Clinical Trials Directory

Trials / Completed

CompletedNCT01724892

Comparison the Effects of Dexamethasone and Loteprednol on Epithelial Healing

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Khon Kaen University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Corticosteroid has been used for the treatment after phototherapeutic keratectomy (PRK). Dexamethasone, a potent steroid can retard the corneal epithelial healing rate and has numerous serious complications, especially glaucoma. Loteprednol, a new generation of corticosteroid has less potency than dexamethasone and was proposed to has less side effect regarding intraocular pressure (IOP) elevation. Therefore, Investigators would like to compare the effect of dexamethasone and loteprednol on corneal epithelial healing rate after PRK and risk of glaucoma.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone
DRUGLoteprednol etabonate

Timeline

Start date
2012-11-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2012-11-12
Last updated
2014-03-17

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01724892. Inclusion in this directory is not an endorsement.